Sepsis is a complex, dynamic syndrome caused by imbalances in the 'inflammatory network', leading to severe dysregulation of the immune response and multi-organ failure. Despite extensive research, the pathophysiology of sepsis remains poorly understood. Sepsis is characterized by an excessive inflammatory response, which can lead to immunosuppression and organ failure. The inflammatory response is initiated by pattern-recognition receptors (PRRs), which detect microbial infections and tissue damage. The complement system, TLR4, and other inflammatory mediators play key roles in the pathogenesis of sepsis. The inflammatory response is further amplified by the release of cytokines, chemokines, and other mediators, leading to a 'cytokine storm'. The complement system, particularly C5a, contributes to the pathogenesis of sepsis by modulating other systems, including coagulation and the release of cytokines. The pro-inflammatory cytokine HMGB1 is also involved in the pathogenesis of sepsis, as it can promote inflammation and disrupt epithelial barriers. The IL-17A cytokine is also involved in the pathogenesis of sepsis, as increased levels can lead to adverse effects. The complement system and coagulation system are closely linked, and their dysregulation contributes to the pathogenesis of sepsis. The autonomic nervous system (ANS) also plays a role in the pathogenesis of sepsis, with the cholinergic anti-inflammatory pathway being a key regulator of the immune response. The sympathetic nervous system can promote the release of pro-inflammatory mediators and contribute to the pathogenesis of sepsis. The enteric nervous system is also involved in the pathogenesis of sepsis, as it can produce catecholamines that contribute to the release of pro-inflammatory cytokines. Targeting the ANS may be a promising approach for the treatment of sepsis. Despite extensive research, none of the promising therapeutic approaches for sepsis that target the inflammatory response have been successfully translated to the clinical setting. Sepsis is a complex, dynamic syndrome with great heterogeneity, and not a distinct disease. The underlying inflammatory response in sepsis involves a complex interplay of different biological systems and cell types, resulting in severe dysregulation of the inflammatory network. Interdisciplinary approaches are needed to improve our understanding of the molecular biology of inflammation in the context of sepsis.Sepsis is a complex, dynamic syndrome caused by imbalances in the 'inflammatory network', leading to severe dysregulation of the immune response and multi-organ failure. Despite extensive research, the pathophysiology of sepsis remains poorly understood. Sepsis is characterized by an excessive inflammatory response, which can lead to immunosuppression and organ failure. The inflammatory response is initiated by pattern-recognition receptors (PRRs), which detect microbial infections and tissue damage. The complement system, TLR4, and other inflammatory mediators play key roles in the pathogenesis of sepsis. The inflammatory response is further amplified by the release of cytokines, chemokines, and other mediators, leading to a 'cytokine storm'. The complement system, particularly C5a, contributes to the pathogenesis of sepsis by modulating other systems, including coagulation and the release of cytokines. The pro-inflammatory cytokine HMGB1 is also involved in the pathogenesis of sepsis, as it can promote inflammation and disrupt epithelial barriers. The IL-17A cytokine is also involved in the pathogenesis of sepsis, as increased levels can lead to adverse effects. The complement system and coagulation system are closely linked, and their dysregulation contributes to the pathogenesis of sepsis. The autonomic nervous system (ANS) also plays a role in the pathogenesis of sepsis, with the cholinergic anti-inflammatory pathway being a key regulator of the immune response. The sympathetic nervous system can promote the release of pro-inflammatory mediators and contribute to the pathogenesis of sepsis. The enteric nervous system is also involved in the pathogenesis of sepsis, as it can produce catecholamines that contribute to the release of pro-inflammatory cytokines. Targeting the ANS may be a promising approach for the treatment of sepsis. Despite extensive research, none of the promising therapeutic approaches for sepsis that target the inflammatory response have been successfully translated to the clinical setting. Sepsis is a complex, dynamic syndrome with great heterogeneity, and not a distinct disease. The underlying inflammatory response in sepsis involves a complex interplay of different biological systems and cell types, resulting in severe dysregulation of the inflammatory network. Interdisciplinary approaches are needed to improve our understanding of the molecular biology of inflammation in the context of sepsis.